Search Within

Matthew Galsky

Formats
  1. Journal Article (15)
  2. Meeting Abstract (9)
  3. Book Section (4)
  4. Book Whole (1)
Groups
  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (20)
  3. Genitourinary Oncology Service (18)
  4. Nursing (8)
  5. Epidemiology and Biostatistics (5)
  6. Surgery (5)

More Groups

People
  1. Dean Bajorin (9)
  2. Howard Scher (8)
  3. William Kelly (8)
  4. Joseph Scattergood (5)
  5. Mary Boyle (5)
  6. Svetlana Mironov (5)

More People

Years
  1. 2021 (1)
  2. 2016 (1)
  3. 2008 (1)
  4. 2007 (5)
  5. 2006 (6)
  6. 2005 (10)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer (3)
  3. Urology (2)
  4. Annals of Oncology (1)
  5. Clinical Cancer Research (1)
  6. Comprehensive Textbook of Genitourinary Oncology. 3rd ed (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (3)
  3. Wiley Blackwell (3)
  4. Elsevier Science, Inc. (2)
  5. Oxford University Press (2)
  6. Springer Verlag (2)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective trial of ifosfamide, paclitaxel, and cisplatin (ITP) in patients with advanced non-transitional cell (non-TCC) carcinomas of the urothelial tract
    Meeting Abstract

    Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Donat, S. M.; Bochner, B. H.; Herr, H. W.; Russo, P.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Violaceous exanthem as a manifestation of metastatic prostate cancer in skin
    Journal Article

    Slovin, S. F.; Galsky, M. D.; Busam, K.
    Urology (2006)

    Fulltext@MSK | Save
  • A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: Second-line taxane-based therapy after first-line epothilone-B analog ixahepilone (BMS-247550) therapy
    Journal Article

    Rosenberg, J. E.; Galsky, M. D.; Rohs, N. C.; Weinberg, V. K.; Oh, W. K.; Kelly, W. K.; Small, E. J.
    Cancer (2006)

    Fulltext@MSK | Save
  • Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
    Journal Article

    Dash, A.; Galsky, M. D.; Vickers, A. J.; Serio, A. M.; Koppie, T. M.; Dalbagni, G.; Bochner, B. H.
    Cancer (2006)

    Fulltext@MSK | Save
  • Hematology and oncology pearls
    Book Whole


    Mosby Elsevier (2005)

    Fulltext@MSK | Save
  • Reverse transcriptase polymerase chain reaction for prostate-specific antigen (RT-PCR PSA) responses may predict time to progression (TTP) in hormone refractory prostate cancer (HRPC) patients treated with chemotherapy
    Meeting Abstract

    Ross, R. W.; Manola, J.; Hennessy, K.; Galsky, M.; Scher, H.; Small, E.; Kelly, W. K.; Kantoff, P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Milowsky, M. I.; Galsky, M.; Lewin, J.; Rozario, C. P.; Owens, L.; Marshall, T.; Nanus, D.; Webb, I. J.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase I/II study of dose-dense sequential chemotherapy in renal impaired patients (Pts) with transitional cell carcinoma (TCC) of the urothelium
    Meeting Abstract

    Galsky, M. D.; Mironov, S.; Scattergood, J.; Dobrzynski, D.; Mitra, N.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients (pts) with transitional cell carcinoma (TCC) of the bladder
    Meeting Abstract

    Dash, A.; Koppie, T.; Vora, K.; Bochner, B.; Galsky, M. D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy
    Journal Article

    Ross, R. W.; Manola, J.; Hennessy, K.; Galsky, M.; Scher, H.; Small, E.; Kelly, W. K.; Kantoff, P. W.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save